The FDA authorized Pfizer’s COVID-19 booster for children 12 to 15 and reduced the wait time between the vaccine’s primary series and booster to five months.
The FDA authorized Pfizer’s COVID-19 booster for children 12 to 15 and reduced the wait time between the vaccine’s primary series and booster to five months.
The FDA authorized Pfizer’s COVID-19 booster for children 12 to 15 and reduced the wait time between the vaccine’s primary series and booster to five months.
Pandemics do eventually end, even if omicron is complicating the question of when this one will. But it won’t be like flipping a light switch: The world will have to learn to coexist with a virus that’s not going away
The FDA authorized Pfizer’s COVID-19 booster for children 12 to 15 and reduced the wait time between the vaccine’s primary series and booster to five months.